Lundbeck, the only pharmaceutical company that supplies pentobarbital to the United States, has said that it will take steps to ensure that its drug will no longer be used for lethal injection. Lundbeck expressed moral opposition to the use of its product in executions. In a statement, the company declared that use of the drug in lethal injection proceedings "contradicts everything we are in business to do - provide therapies that improve people's lives." This news comes after a self-initiated industry boycott of sodium thiopental left states scrambling to find a replacement drug. Pentobarbital filled this void, but questions have been raised over the constitutionality of the drug. Little research has been conducted about any possible pain condemned inmates might have to endure with this new combination of drugs; inmates are paralyzed during the proceedings and cannot, therefore, physically express pain. If Lundbeck's boycott is effective, states will have to find yet another alternative drug.
Pentobarbital has been commonly used as an animal euthanasia drug. Recently there was a row over this issue in Texas when the ACLU published a report juxtaposing the state's regulation of veterinarians and prison officials: "Veterinarians in Texas are prohibited from using the combination of drugs that the Texas Department of Criminal Justice has deemed suitable for the execution of human beings," the report finds. The paper also details the numerous medical and professional qualifications veterinarians must have before they are allowed to euthanize animals. Prison officials, however, are granted a tremendous amount of discretion and autonomy when planning and administering a lethal injection execution. The report concludes that "it is no exaggeration to say that Texas regulates the euthanasia of reptiles more strictly than the execution of human beings."
Posted in Blog
Comments are now closed for this item.